Joel Isaacson & Co., LLC Eli Lilly & CO Transaction History

Joel Isaacson & Co., LLC

$2.07 Billion
Q3 2024

A detailed history of Joel Isaacson & Co., LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Joel Isaacson & Co., LLC holds 4,830 shares of LLY stock, worth $4.39 Million. This represents 0.21% of its overall portfolio holdings.

Number of Shares

4,830

Previous 5,240 7.82%

Holding current value

$4.39 Million

Previous $4.74 Million 9.8%

% of portfolio

0.21%

Previous 0.25%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 23, 2024	SELL	$772.14 - $960.02 $316,577 - $393,608	-410 Reduced 7.82%	4,830 $4.28 Million
Q2 2024 Jul 23, 2024	SELL	$724.87 - $909.04 $65,238 - $81,813	-90 Reduced 1.69%	5,240 $4.74 Million
Q1 2024 Apr 29, 2024	BUY	$592.2 - $792.28 $194,241 - $259,867	328 Added 6.56%	5,330 $4.15 Million
Q4 2023 Jan 24, 2024	BUY	$525.19 - $619.13 $15,230 - $17,954	29 Added 0.58%	5,002 $2.92 Million
Q3 2023 Oct 23, 2023	BUY	$434.7 - $599.3 $55,206 - $76,111	127 Added 2.62%	4,973 $2.67 Million
Q2 2023 Jul 26, 2023	BUY	$350.74 - $468.98 $37,879 - $50,649	108 Added 2.28%	4,846 $2.27 Million
Q1 2023 Apr 24, 2023	SELL	$310.63 - $364.82 $24,850 - $29,185	-80 Reduced 1.66%	4,738 $1.63 Million
Q4 2022 Jan 27, 2023	BUY	$321.55 - $374.67 $36,656 - $42,712	114 Added 2.42%	4,818 $0
Q3 2022 Oct 13, 2022	SELL	$296.48 - $337.87 $358,444 - $408,484	-1,209 Reduced 20.45%	4,704 $1.52 Million
Q2 2022 Jul 15, 2022	BUY	$278.73 - $327.27 $5,295 - $6,218	19 Added 0.32%	5,913 $1.92 Million
Q4 2021 Jan 19, 2022	BUY	$224.85 - $279.04 $78,697 - $97,664	350 Added 6.31%	5,894 $1.63 Million
Q3 2021 Oct 21, 2021	BUY	$221.6 - $272.71 $165,978 - $204,259	749 Added 15.62%	5,544 $1.28 Million
Q2 2021 Jul 20, 2021	BUY	$180.55 - $233.54 $9,749 - $12,611	54 Added 1.14%	4,795 $1.1 Million
Q1 2021 Apr 23, 2021	BUY	$164.32 - $212.72 $44,859 - $58,072	273 Added 6.11%	4,741 $886,000
Q4 2020 Jan 22, 2021	SELL	$130.46 - $172.63 $27,787 - $36,770	-213 Reduced 4.55%	4,468 $754,000
Q3 2020 Oct 14, 2020	BUY	$146.22 - $169.13 $1,900 - $2,198	13 Added 0.28%	4,681 $693,000
Q2 2020 Jul 21, 2020	BUY	$136.42 - $164.18 $13,641 - $16,418	100 Added 2.19%	4,668 $766,000
Q1 2020 Apr 21, 2020	SELL	$119.05 - $147.35 $131,669 - $162,969	-1,106 Reduced 19.49%	4,568 $634,000
Q3 2019 Oct 15, 2019	SELL	$106.79 - $116.16 $69,840 - $75,968	-654 Reduced 10.34%	5,674 $635,000
Q2 2019 Jul 11, 2019	SELL	$110.79 - $129.32 $542,317 - $633,021	-4,895 Reduced 43.62%	6,328 $701,000
Q1 2019 Apr 09, 2019	BUY	$111.31 - $131.02 $80,254 - $94,465	721 Added 6.87%	11,223 $1.46 Million
Q4 2018 Jan 18, 2019	BUY	$105.9 - $118.64 $761,209 - $852,784	7,188 Added 216.9%	10,502 $1.22 Million
Q3 2017 Nov 02, 2017	BUY	$77.07 - $85.54 $255,409 - $283,479	3,314	3,314 $283,000

Others Institutions Holding LLY

# of Institutions

3,887

Shares Held

763M

Call Options Held

6.34M

Put Options Held

7.97M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $864B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Joel Isaacson & Co., LLC, based on Form 13F filings with the SEC.

News

Stay updated on Joel Isaacson & Co., LLC with notifications on news.

Account

Joel Isaacson & Co., LLC Eli Lilly & CO Transaction History